SCHEMBL28156802

SCHEMBL28156802

CN(Cc1ccccc1)S(=O)(=O)c1ccc(NC(=O)c2ccccc2F)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.54
▸ HDAC6 Q9UBN7 1/20 0.54
▸ MAPT P10636 5/20 0.52
▸ TP53 P04637 2/20 0.52
▸ RXFP1 Q9HBX9 5/20 0.50
▸ THRB P10828 1/20 0.50
▸ LMNA P02545 3/20 0.49
▸ POLB P06746 2/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SENP7 Q9BQF6 1/20 0.48
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ TNF P01375 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28157313 0.93 RXFP1 (0.46) HDAC4HDAC6MAPTTP53RXFP1
SCHEMBL28156807 0.91 MEN1 (0.53) HDAC4HDAC6MAPTTP53RXFP1
SCHEMBL28156782 0.85 LMNA (0.42) MAPTTP53RXFP1LMNAPOLB
SCHEMBL28156810 0.84 MAPT (0.42) MAPTTP53RXFP1LMNAPOLB
SCHEMBL28157366 0.83 MAPT (0.41) HDAC4HDAC6MAPTTP53LMNA
SCHEMBL28846370 0.82 GSTO1 (0.42) MAPTTP53LMNAPOLBCASP3
SCHEMBL28157364 0.82 LMNA (0.45) MAPTTP53RXFP1LMNAPOLB
SCHEMBL16246408 0.81 CFTR (0.68) HDAC4HDAC6MAPTTP53RXFP1
SCHEMBL28157321 0.79 TP53 (0.44) MAPTTP53RXFP1LMNAPOLB
SCHEMBL28157305 0.79 MEN1 (0.48) MAPTTP53RXFP1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback